Concept Life Sciences (CLS), a UK-based drug discovery, development, and manufacturing organization backed by Limerston Capital, has completed the acquisition of Charnwood Discovery.   The deal bolsters CLS’s position as a leading pharmaceutical and life science services provider, aligning with its ambitious growth strategy. Charnwood Discovery, a renowned UK-based drug discovery research firm, brings a strong global client base and expertise in chemistry, biology, and ADME/DMPK.   The integ...